Indivior Pharmaceuticals, Inc. Declares Special Cash Dividend
IN
INDV INDV
$35.82
▼ -0.50%
($-0.18)
Open
$35.90
Prev Close
$36.00
Day Range
$35.72 – $36.22
52W Range
$22.56 – $42.81
P/E (TTM)
11.91
Beta
0.50
EPS (TTM)
$2.78
📋 Company Profile
| Employees | 838 |
| Listed | 2014-12-24 |
| Shares Out. | 118,031,934 |
| Website | indivior.com ↗ |
| Revenue | $343.0M |
| Gross Profit | $293.0M |
| Net Income | $122.0M |
| Free Cash Flow | -$111.0M |
| Total Assets | $1.23B |
| Total Liabilities | $1.44B |
| Equity | -$208.0M |
About INDV
Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company derives revenues from customers through the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence and related disorders. The company's products include: Sublocade (buprenorphine extended-release monthly injection), and Suboxone (buprenorphine and naloxone sublingual film).
INDV is a publicly traded company under the ticker symbol INDV. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
10 analysts (2026-09-01)